N-power Medicine

This study is collecting information from 130 people with advanced EGFR-mutant non-small cell lung cancer who are starting treatment with osimertinib. Researchers want to see how long the drug controls the cancer in real-world settings, outside of strict clinical trial conditions…

This study is collecting information from 650 people with advanced lung cancer to create 'control arms' — groups that help researchers compare how well new treatments work. Participants will receive standard therapies, and their outcomes will be tracked. The goal is to make futur…

This study is a large registry that collects information from adult cancer patients during their routine care. Researchers will track treatments, side effects, and outcomes to better understand how cancer is managed in real-world settings. Up to 20,000 participants will be enroll…